Ophthalmology Pipeline  Database – 2016

Ophthalmology Pipeline Database – 2016

  • January 2016 •
  • Report ID: 3895216 •
  • Format: PDF
Ophthalmology Pipeline Highlights Database – 2016, provides most up-to-date information on key pipeline molecules in the global Ophthalmology Drug market. It covers emerging therapies for Ophthalmology disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Conjunctivitis, Glaucoma, Diabetic Retinopathy, Myasthenia gravis, Dry Eye Syndrome, Age-related Macular Degeneration, and Cataract. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:
The report presents pipeline by Ophthalmology indications. Key indications covered in this report include Conjunctivitis, Glaucoma, Diabetic Retinopathy, Myasthenia gravis, Dry Eye Syndrome, Age-related Macular Degeneration, and Cataract.

By Clinical Trial Stages:
The report provides Ophthalmology pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:
The report provides Ophthalmology pipeline molecules by their dominant drug mechanism class. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:
The report provides Ophthalmology pipeline molecules by the developing company and the partnered company.

SUMMARY:
- Ophthalmology Pipeline by Indication
- Ophthalmology Pipeline by Clinical Trial Phase
- Ophthalmology Pipeline by Drug Mechanism Classes
- Ophthalmology Pipeline by Company